metsera glp 1 Pfizer to buy weight-loss drug firm for $4.9 billion Ugliness in the competitive GLP-1

Nearly half of people who say they have been diagnosed with diabetes (45%) report currently using a GLP-1 medication, as do three in ten (29%) adults who say theyve been diagnosed with heart disease and about a quarter (23%) of those who report being diagnosed as overweight or obese in the past five years

Some patients report fluctuations in bowel habits on GLP-1 medications

PlexusDx supports precision-guided conversations by offering both compounded GLP-1 access and optional genetic testing to explore peptide pathway predispositions

Factors That Determine Your Personal Treatment Duration Your unique genetics, starting health status, and lifestyle habits all influence how long you'll benefit from GLP-1 therapy